814.17
price down icon2.47%   -20.58
after-market アフターアワーズ: 814.16 -0.010 -0.00%
loading
前日終値:
$834.75
開ける:
$838.27
24時間の取引高:
670.52K
Relative Volume:
1.78
時価総額:
$49.83B
収益:
$3.06B
当期純損益:
$1.28B
株価収益率:
41.39
EPS:
19.6719
ネットキャッシュフロー:
$447.35M
1週間 パフォーマンス:
-0.18%
1か月 パフォーマンス:
+10.02%
6か月 パフォーマンス:
+35.72%
1年 パフォーマンス:
+43.22%
1日の値動き範囲:
Value
$813.30
$839.66
1週間の範囲:
Value
$813.30
$855.46
52週間の値動き範囲:
Value
$510.06
$855.46

Argen X Se Adr Stock (ARGX) Company Profile

Name
名前
Argen X Se Adr
Name
セクター
Healthcare (1138)
Name
電話
-
Name
住所
-
Name
職員
1,639
Name
Twitter
Name
次回の収益日
2024-10-31
Name
最新のSEC提出書
Name
ARGX's Discussions on Twitter

ARGX を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ARGX
Argen X Se Adr
814.17 51.39B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
426.44 109.29B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
464.90 62.13B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
584.74 61.40B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ONC
Beone Medicines Ltd Adr
313.54 34.68B 4.56B -176.77M 225.30M -1.7177

Argen X Se Adr Stock (ARGX) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-09-15 再開されました Truist Buy
2025-09-11 ダウングレード Deutsche Bank Buy → Hold
2025-08-25 開始されました RBC Capital Mkts Outperform
2025-07-08 アップグレード Deutsche Bank Hold → Buy
2025-07-03 再開されました Morgan Stanley Overweight
2025-05-13 アップグレード Robert W. Baird Neutral → Outperform
2025-03-17 アップグレード Bernstein Mkt Perform → Outperform
2025-03-12 アップグレード Deutsche Bank Sell → Hold
2025-01-17 ダウングレード Deutsche Bank Hold → Sell
2024-11-12 アップグレード Wolfe Research Peer Perform → Outperform
2024-11-05 アップグレード Scotiabank Sector Perform → Sector Outperform
2024-11-01 ダウングレード Robert W. Baird Outperform → Neutral
2024-11-01 アップグレード William Blair Mkt Perform → Outperform
2024-10-10 再開されました Raymond James Strong Buy
2024-10-04 ダウングレード Deutsche Bank Buy → Hold
2024-08-06 アップグレード Barclays Equal Weight → Overweight
2024-07-25 アップグレード Deutsche Bank Hold → Buy
2024-07-23 アップグレード Oppenheimer Perform → Outperform
2024-02-15 開始されました Wolfe Research Peer Perform
2023-12-20 ダウングレード Deutsche Bank Buy → Hold
2023-12-20 ダウングレード William Blair Outperform → Mkt Perform
2023-07-31 開始されました Scotiabank Sector Perform
2023-07-24 ダウングレード UBS Buy → Neutral
2023-07-17 再開されました Evercore ISI Outperform
2023-06-15 開始されました Societe Generale Sell
2023-05-31 開始されました UBS Buy
2023-04-25 開始されました Citigroup Buy
2023-03-14 アップグレード Robert W. Baird Neutral → Outperform
2022-12-07 開始されました William Blair Outperform
2022-10-12 開始されました Oppenheimer Perform
2022-07-29 ダウングレード Robert W. Baird Outperform → Neutral
2022-06-28 再開されました Stifel Buy
2022-05-03 アップグレード Morgan Stanley Equal-Weight → Overweight
2021-12-08 開始されました Wells Fargo Overweight
2021-11-29 アップグレード Piper Sandler Neutral → Overweight
2021-10-29 アップグレード Guggenheim Neutral → Buy
2021-10-28 アップグレード Raymond James Outperform → Strong Buy
2021-10-07 開始されました Jefferies Buy
2021-09-23 アップグレード Redburn Neutral → Buy
2021-09-07 ダウングレード Morgan Stanley Overweight → Equal-Weight
2021-07-23 開始されました Deutsche Bank Hold
2021-07-19 再開されました Wolfe Research Outperform
2021-06-18 開始されました UBS Buy
2021-06-04 再開されました Robert W. Baird Outperform
2021-05-10 アップグレード H.C. Wainwright Neutral → Buy
2021-04-23 開始されました Redburn Neutral
2021-03-05 繰り返されました H.C. Wainwright Neutral
2021-02-02 ダウングレード Piper Sandler Overweight → Neutral
2021-01-04 ダウングレード Guggenheim Buy → Neutral
2020-08-25 開始されました Raymond James Outperform
2020-08-19 ダウングレード Evercore ISI Outperform → In-line
2020-07-29 開始されました H.C. Wainwright Neutral
2020-02-10 開始されました BofA/Merrill Buy
2019-11-05 開始されました Credit Suisse Neutral
2019-10-31 アップグレード William Blair Mkt Perform → Outperform
2019-10-22 開始されました JP Morgan Overweight
2019-09-27 開始されました Wells Fargo Market Perform
2019-09-16 再開されました Cowen Outperform
2019-06-28 開始されました Robert W. Baird Outperform
2019-01-18 再開されました SunTrust Buy
2019-01-04 開始されました Morgan Stanley Overweight
2018-12-17 開始されました Goldman Buy
2018-12-14 開始されました Wolfe Research Outperform
2018-06-29 開始されました Nomura Buy
2018-04-09 開始されました SunTrust Buy
2018-01-29 繰り返されました JMP Securities Mkt Outperform
すべてを表示

Argen X Se Adr (ARGX) 最新ニュース

pulisher
Oct 16, 2025

TD Cowen Remains a Buy on Argenx Se (ARGX) - The Globe and Mail

Oct 16, 2025
pulisher
Oct 15, 2025

argenx stock price target maintained at $800 by TD Cowen on strong Vyvgart uptake - Investing.com

Oct 15, 2025
pulisher
Oct 15, 2025

Argenx Se (ARGX) Gets a Buy from Evercore ISI - The Globe and Mail

Oct 15, 2025
pulisher
Oct 13, 2025

How Do Investors Really Feel About argenx SE? - Sahm

Oct 13, 2025
pulisher
Oct 10, 2025

RBC Capital Remains a Buy on Argenx Se (ARGX) - The Globe and Mail

Oct 10, 2025
pulisher
Oct 08, 2025

Argenx NV stock hits all-time high at 803.95 USD By Investing.com - Investing.com South Africa

Oct 08, 2025
pulisher
Oct 08, 2025

Argenx NV stock hits all-time high at 803.95 USD - Investing.com

Oct 08, 2025
pulisher
Oct 04, 2025

Argenx SE Calls Extraordinary Shareholder Meeting for November 2025 - The Globe and Mail

Oct 04, 2025
pulisher
Oct 03, 2025

Goldman Sachs Sticks to Its Buy Rating for Argenx Se (ARGX) - The Globe and Mail

Oct 03, 2025
pulisher
Oct 02, 2025

Argenx stock hits all-time high at 781.12 USD By Investing.com - Investing.com Australia

Oct 02, 2025
pulisher
Oct 01, 2025

Argenx stock hits all-time high at 781.12 USD - Investing.com

Oct 01, 2025
pulisher
Oct 01, 2025

Argenx Se (ARGX) Gets a Buy from Morgan Stanley - The Globe and Mail

Oct 01, 2025
pulisher
Sep 30, 2025

Argenx Se (ARGX) Receives a Buy from RBC Capital - The Globe and Mail

Sep 30, 2025
pulisher
Sep 29, 2025

Here's How Much $100 Invested In argenx 5 Years Ago Would Be Worth Today - Sahm

Sep 29, 2025
pulisher
Sep 26, 2025

Price Over Earnings Overview: argenx - Sahm

Sep 26, 2025
pulisher
Sep 20, 2025

Leerink Partners Keeps Their Buy Rating on Viridian Therapeutics (VRDN) - The Globe and Mail

Sep 20, 2025
pulisher
Sep 18, 2025

Argenx Se (ARGX) Receives a Rating Update from a Top Analyst - The Globe and Mail

Sep 18, 2025
pulisher
Sep 18, 2025

Oppenheimer reaffirms Outperform rating on argenx stock after positive data - Investing.com

Sep 18, 2025
pulisher
Sep 17, 2025

Truist Securities reiterates Buy rating on argenx stock with $918 target - Investing.com

Sep 17, 2025
pulisher
Sep 16, 2025

$1000 Invested In argenx 5 Years Ago Would Be Worth This Much Today - Sahm

Sep 16, 2025
pulisher
Sep 16, 2025

Analysts Offer Insights on Healthcare Companies: Abivax SA Sponsored ADR (ABVX), KalVista Pharmaceuticals (KALV) and Argenx Se (ARGX) - The Globe and Mail

Sep 16, 2025
pulisher
Sep 15, 2025

Truist Securities assumes coverage on argenx stock with Buy rating - Investing.com

Sep 15, 2025
pulisher
Sep 12, 2025

Deutsche Bank downgrades Argenx to “hold” after 40% rally, €655 PT intact - Investing.com

Sep 12, 2025
pulisher
Sep 08, 2025

14 Newly Overvalued Stocks for the Week - Morningstar

Sep 08, 2025
pulisher
Sep 08, 2025

BofA Securities reaffirms Buy rating on argenx stock with $887 target - Investing.com

Sep 08, 2025
pulisher
Sep 03, 2025

Argenx stock hits all-time high at 716.89 USD - Investing.com

Sep 03, 2025
pulisher
Aug 27, 2025

Stocks Showing Improving Market Leadership: argenx ADR Earns 84 RS Rating - MSN

Aug 27, 2025
pulisher
Aug 26, 2025

Argenx Stock Hits Record High After Reporting 664% Earnings Surge; This Rating Upgraded - Investor's Business Daily

Aug 26, 2025
pulisher
Aug 26, 2025

Piper Sandler raises argenx stock price target to $820 on Vyvgart success - Investing.com

Aug 26, 2025
pulisher
Aug 25, 2025

Argenx Tops Buy Point On Bullish Study, 850 Price Target - Investor's Business Daily

Aug 25, 2025
pulisher
Aug 25, 2025

Argenx stock reaches all-time high at 696.94 USD - Investing.com

Aug 25, 2025
pulisher
Aug 25, 2025

Argenx: study met primary endpoint - AInvest

Aug 25, 2025
pulisher
Aug 25, 2025

argenx Announces Positive Topline Results from ADAPT SERON Study of VYVGART in Patients with AChR-Ab Seronegative gMG - GlobeNewswire Inc.

Aug 25, 2025
pulisher
Aug 21, 2025

Argenx Shares Rise 0.42% with $190M Volume Ranking 464th Amid Biotech Sector Surge - AInvest

Aug 21, 2025
pulisher
Aug 21, 2025

European ADRs Under Pressure: Sector Divergence and Strategic Entry Points - AInvest

Aug 21, 2025
pulisher
Aug 21, 2025

Earnings call transcript: Argenx Q2 2025 reports robust earnings beat - Investing.com

Aug 21, 2025
pulisher
Aug 19, 2025

Argenx's Growth Fuels Strong Demand for Vyvgart; Pipeline Continues to Develop - Morningstar

Aug 19, 2025
pulisher
Aug 17, 2025

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of argenx SE - GlobeNewswire Inc.

Aug 17, 2025
pulisher
Aug 15, 2025

This Stock Ran 31% In A Month. Will Upcoming News Revitalize It? - Investor's Business Daily

Aug 15, 2025
pulisher
Aug 12, 2025

argenx and Tennis Legend Monica Seles Team Up to Raise Awareness of Myasthenia Gravis - Sahm

Aug 12, 2025
pulisher
Aug 08, 2025

argenx ADR Earns Relative Strength Rating Upgrade; Hits Key Benchmark - inkl

Aug 08, 2025
pulisher
Jul 31, 2025

Argenx NV ADR stock reaches all-time high at 689.13 USD By Investing.com - Investing.com South Africa

Jul 31, 2025
pulisher
Jul 31, 2025

Argenx NV ADR stock reaches all-time high at 689.13 USD - Investing.com Nigeria

Jul 31, 2025
pulisher
Jul 31, 2025

argenx ADR earnings beat by $3.26, revenue topped estimates - Investing.com South Africa

Jul 31, 2025
pulisher
Jul 31, 2025

BofA Securities raises argenx stock price target to $880 on strong Vyvgart sales - Investing.com

Jul 31, 2025
pulisher
Jul 21, 2025

Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace

Jul 21, 2025
pulisher
Jul 15, 2025

BofA Securities raises argenx stock price target to $829 on Vyvgart growth - Investing.com

Jul 15, 2025
pulisher
Jul 03, 2025

Morgan Stanley assumes coverage on argenx stock with Overweight rating - Investing.com

Jul 03, 2025
pulisher
Jul 01, 2025

Argenx stock advances as H.C. Wainwright reiterates Buy rating - Investing.com

Jul 01, 2025
pulisher
Jun 30, 2025

Argenx stock falls after FDA flags serious risk signal with Vyvgart - Investing.com

Jun 30, 2025
pulisher
Jun 11, 2025

Argenx stock price target reiterated at $761 on positive trial data - Investing.com

Jun 11, 2025

Argen X Se Adr (ARGX) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$584.74
price up icon 0.93%
$464.90
price down icon 1.92%
biotechnology ONC
$313.54
price down icon 0.70%
$160.40
price down icon 2.97%
$106.23
price down icon 0.62%
大文字化:     |  ボリューム (24 時間):